PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
30/26/30	SEK 0.3150	+1.94%	28,021
29/26/29	SEK 0.3090	-2.52%	1,15,159

End-of-day quote SPOTLIGHT STOCK MARKET AB

More quotes

End-of-day quote SPOTLIGHT STOCK MARKET AB 30/09/2026			5-day change	1st Jan Change
0.3150 ^SEK	+1.94%		+1.94%	+44.50%

29/09	Pexa saw strong interest at the ERS lung congress	FW
03/09	Pexa technology featured in three research presentations at pulmonary congress	FW

Market Cap	2.71Cr 27.12L 24.08L 22.53L 20.42L 38.57L 26Cr 38.85L 1.05Cr 13Cr 1.02Cr 99.63L 43Cr	P/E 2023	-2.18x	P/E 2024	-1.13x
Enterprise Value	2.15Cr 21.52L 19.1L 17.87L 16.2L 30.6L 21Cr 30.82L 83.5L 11Cr 80.77L 79.03L 34Cr	EV / Sales 2023	3.92x	EV / Sales 2024	8.49x
Free-Float	-	Yield 2023 *	-	Yield 2024	-

Markets		Quality
SPOTLIGHT STOCK MARKET AB	PEXA B	End-of-day quote
Deutsche Boerse AG	FA0	Delayed

29/09	Pexa saw strong interest at the ERS lung congress	FW
03/09	Pexa technology featured in three research presentations at pulmonary congress	FW
28/08	Pexa reports modest performance shifts, CEO: new capital provides substantially greater flexibility	FW
28/08	PExA AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
20/08	Pexa's directed share issue registered after positive decision from ISP	FW
19/08	Pexa technology draws attention after silicosis study in Australia	FW
28/07	Pexa's rights issue was oversubscribed	FW
13/07	Pexa - Interview with CEO Tomas Gustafsson	FW
10/07	Pexa raises SEK10m in a directed share issue, Anders Hallberg becomes a major shareholder	FW
01/07	Pexa raises nearly 10 million kronor in fully guaranteed rights issue	FW
23/06	Pexa signs a SEK 7.5m contract with a global pharmaceutical company	FW
10/06	Pexa secures order from the US	FW
02/06	Doctoral thesis presents findings from studies using Pexa technology	FW

PExA AB Share Price

Stocks

PEXA B

SE0007412374

Advanced Medical Equipment & Technology

Valuation: PExA AB

Chart: PExA AB

Latest news: PExA AB

Analysts' recommendations: PExA AB

Press Releases: PExA AB

Quotes and Performance

Price Extremes

Managers and Directors: PExA AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

07/11	Pexa - Q3 Presentation 2025	FW
07/11	Pexa Reports Minor Earnings Changes as Company Advances Toward Diagnostic Applications	FW

04/09	PExA : at the world’s largest respiratory congress – three accepted abstracts featuring PExA to be presented	PU
23/06	PExA : signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million	PU
10/06	PExA : U.S. government agency customer orders upgrade of existing PExA system	PU
02/06	PExA : New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases	PU
13/05	PExA : partner in Dutch precision medicine project within COPD and interstitial lung diseases	PU

1 day	+1.94%
1 week	+1.94%
1 month	-11.27%
3 months	-35.58%
6 months	+45.83%
Current year	+44.50%

1 month	0.3	0.38
Current year	0.18	0.83
1 year	0.14	0.83
3 years	0.14	0.83
5 years	0.14	1.94
10 years	0.14	9.75

Manager	Title	Age	Since
Bengt Tomas Jan Gustafsson CEO	Chief Executive Officer	55	-
Jörgen Östling CTO	Chief Tech/Sci/R&D Officer	-	01/01/2018
Svante Höjer CTO	Chief Tech/Sci/R&D Officer	65	01/01/2015

Director	Title	Age	Since
Anna-Carin Olin BRD	Director/Board Member	66	01/01/2010
Claes Frederik Holmberg CHM	Chairman	72	31/01/2014
Björn Lennart Dahlöf BRD	Director/Board Member	73	01/01/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PEXA AB	+1.94%	+1.94%	+94.44%	-21.64%	39.19L
THERMO FISHER SCIENTIFIC, INC.	-0.05%	-3.39%	+20.71%	+31.70%	24TCr
DANAHER CORPORATION	-0.47%	-4.64%	+1.84%	-0.75%	15TCr
INTUITIVE SURGICAL, INC.	+0.89%	-1.80%	-9.99%	+36.89%	14TCr
BOSTON SCIENTIFIC CORPORATION	-0.02%	-3.85%	-56.37%	-19.05%	6.11TCr
EDWARDS LIFESCIENCES CORPORATION	+0.71%	-1.82%	+12.96%	+17.34%	4.98TCr
AGILENT TECHNOLOGIES, INC.	-0.75%	-3.26%	+19.57%	+53.05%	4.77TCr
SIEMENS HEALTHINEERS AG	+0.77%	+1.55%	-20.54%	-17.92%	4.77TCr
VEEVA SYSTEMS INC.	+0.01%	+1.77%	-5.42%	+35.26%	4.59TCr
ILLUMINA, INC.	-2.87%	+0.57%	+170.78%	+95.36%	4.13TCr
Average	+0.05%	-1.30%	+22.80%	+21.02%	8.31TCr
Weighted average by Cap.	-0.04%	-1.28%	+9.43%	+23.82%

	2023	2024
Net sales	20.15L 2L 2L 2L 2L 3L 1.95Cr 3L 8L 99.33L 8L 7L 3.19Cr	7L 72.13T 64.03T 59.92T 54.31T 1L 69.53L 1L 3L 35.47L 3L 3L 1.14Cr
Net income	-80.44L -8L -7L -7L -6L -11.46L -7.77Cr -11.55L -31.28L -3.96Cr -30.26L -29.61L -13Cr	-1.02Cr -10.19L -9L -8L -8L -14.48L -9.82Cr -14.59L -39.53L -5.01Cr -38.23L -37.41L -16Cr
Net Debt	-96L -10L -9L -8L -7L -13.68L -9.28Cr -13.78L -37.34L -4.73Cr -36.12L -35.34L -15Cr	-55.93L -6L -5L -5L -4L -8L -5.4Cr -8L -21.76L -2.76Cr -21.04L -20.59L -8.86Cr